New gene therapy combo shows promise in ovarian cancer trial
Disease control
Ongoing
This study tests whether adding a gene therapy called IMNN-001 to standard chemotherapy can help people with advanced ovarian, fallopian tube, or peritoneal cancer live longer without their cancer growing. About 130 newly diagnosed patients will receive either the combination or …
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC